1. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan et al, 2017, Cell Biosci CrossRef
  2. Apigenin: A dietary flavonoid with diverse anticancer properties
    Josip Madunić et al, 2018, Cancer Letters CrossRef
  3. Anticancer agents interacting with membrane glucose transporters.
    C Granchi et al, 2016, Medchemcomm CrossRef
  4. Downregulation of miRNA-26b inhibits cancer proliferation of laryngeal carcinoma through autophagy by targeting ULK2 and inactivation of the PTEN/AKT pathway
    Shujing Wang et al, 2017 CrossRef
  5. Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress
    YOON-MI LEE et al, 2016 CrossRef
  6. Acute metabolic actions of the major polyphenols in chamomile: an in vitro mechanistic study on their potential to attenuate postprandial hyperglycaemia
    Jose A. Villa-Rodriguez et al, 2018, Sci Rep CrossRef
  7. Role of metabolism in cancer cell radioresistance and radiosensitization methods
    Le Tang et al, 2018, J Exp Clin Cancer Res CrossRef
  8. Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells
    Wenhe Zhu et al, 2018, RSC Adv. CrossRef
  9. Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1
    Xiaofang Chen et al, 2018, RSC Adv. CrossRef
  10. Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy
    Mathieu Sertorio et al, 2018, International Journal of Particle Therapy CrossRef
  11. Vicenin-2 acts as a radiosensitizer of the non-small cell lung cancer by lowering Akt expression
    Taranga Jyoti Baruah et al, 2018, BioFactors CrossRef
  12. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo
    Xing-Mei Luo et al, 2015, PLoS ONE CrossRef
  13. Apigenin as an anticancer agent.
    Muhammad Imran et al, 2020, Phytother Res CrossRef
  14. Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy.
    Mohammad Mirza-Aghazadeh-Attari et al, 2020, Life Sci CrossRef
  15. Effect of combination of curcumin and GLUT ‐1 AS‐ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy
    Li‐Bo Dai et al, 2020, Head & Neck CrossRef
  16. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer
    Hang Yang et al, 2019, Oncotarget CrossRef
  17. Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
    Michael Troncone et al, 2017, Oncotarget CrossRef
  18. Allicin enhances the radiosensitivity of colorectal cancer cells via inhibition of NF‐κB signaling pathway
    Wen‐liang Huang et al, 2020, Journal of Food Science CrossRef
  19. Diosgenin, a steroidal saponin, and its analogues: Effective therapies against different chronic diseases
    Dey Parama et al, 2020, Life Sciences CrossRef
  20. Power of two: Combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
    Kalpana Tilekar et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  21. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
    Alexander E. Kabakov et al, 2021, Cancers CrossRef
  22. Metabolic Reprogramming and Inflammatory Response Induced by D-Lactate in Bovine Fibroblast-Like Synoviocytes Depends on HIF-1 Activity
    John Quiroga et al, 2021, Front. Vet. Sci. CrossRef
  23. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
    Jing Cui et al, 2021, Mol Med CrossRef
  24. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery
    Dennis Jun Jie Poon et al, 2021, Cancer Letters CrossRef
  25. Radiosensitizing effects of curcumin alone or combined with GLUT1 siRNA on laryngeal carcinoma cells through AMPK pathway‐induced autophagy
    Li‐Bo Dai et al, 2021, J Cell Mol Med CrossRef
  26. The Role of Glucose Transporters in Oral Squamous Cell Carcinoma
    Heinrich Botha et al, 2021, Biomolecules CrossRef
  27. Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma
    Xiao-Hong Chen et al, 2021, CMAR CrossRef
  28. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
    Kimberley M. Hanssen et al, 2021, Drug Resistance Updates CrossRef
  29. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  30. Reactive oxygen species: Key players in the anticancer effects of apigenin?
    Omolola R. Oyenihi et al, 2022, Journal of Food Biochemistry CrossRef
  31. A positive feedback circuit comprising p21 and HIF‐1α aggravates hypoxia‐induced radioresistance of glioblastoma by promoting Glut1/LDHA‐mediated glycolysis
    Xiaodong Jin et al, 2022, The FASEB Journal CrossRef
  32. Effect of Glut‐1 and HIF‐1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway
    Yang‐Yang Bao et al, 2022, J Cellular Molecular Medi CrossRef
  33. Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer
    Zecong Xiao et al, 2022, Nano Today CrossRef
  34. The Anticancer Potential of Apigenin Via Immunoregulation
    Lu Xu et al, 2021, CPD CrossRef
  35. Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation
    Avgi Tsolou et al, 2022, International Journal of Radiation Biology CrossRef
  36. Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
    Anastasios Goulioumis et al, 2022, Biomedicines CrossRef
  37. The Potential Role of Apigenin in Cancer Prevention and Treatment
    Arshad Husain Rahmani et al, 2022, Molecules CrossRef
  38. Advances in Dietary Phenolic Compounds to Improve Chemosensitivity of Anticancer Drugs
    Abdelhakim Bouyahya et al, 2022, Cancers CrossRef
  39. Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
    Yuting Cui et al, 2022, Front. Pharmacol. CrossRef
  40. Regulatory Mechanism on Anti-Glycolytic and Anti-Metastatic Activities Induced by Strobilanthes crispus in Breast Cancer, In Vitro
    Siti Nur Hasyila Muhammad et al, 2023, Pharmaceuticals CrossRef
  41. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – a potential contribution to the predictive, preventive, and personalized medicine
    Alena Mazurakova et al, 2023, Journal of Advanced Research CrossRef
  42. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics
    Sahiti Chamarthy et al, 2023, Metab Brain Dis CrossRef
  43. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma
    Bing Li, 2023, Diagn Pathol CrossRef
  44. The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors
    Jacqueline-Katrin Kranjčević et al, 2024, Cancers CrossRef
  45. Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
    Amin Iranpanah et al, 2024, Phytotherapy Research CrossRef